Estimates Revisions PharmaEssentia Corporation
Stocks
6446
TW0006446008
Biotechnology & Medical Research
|
End-of-day quote
Taiwan S.E.
31/08/2026
|
5-day change | 1st Jan Change | ||
| 1,395.00 TWD | -9.71% |
|
-0.36% | +229.24% |
| 10:21am | PharmaEssentia Gets US FDA's Approval for Essential Thrombocythemia Treament Drug; Shares Sink 10% | MT |
| 29/08 | US FDA approves Takeda, Protagonist's drug for rare blood cancer | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 6446 Stock
- Consensus PharmaEssentia Corporation
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
